Q5136 Injection. denosumab-bbdz, 1 milligrams
Also known as: Denosumab-bbdz injection, RANK ligand inhibitor
Injection of denosumab-bbdz biosimilar per 1 milligram, a receptor activator of nuclear factor kappa-B ligand inhibitor.
In Plain Language
bone loss prevention injection; osteoporosis medication
Clinical Context
Used for osteoporosis, bone metastases, multiple myeloma, and giant cell tumors of bone.
RVU Information
CPT Q5136 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5136?
CPT Q5136 (Injection. denosumab-bbdz, 1 milligrams) is a Q Codes code. Injection of denosumab-bbdz biosimilar per 1 milligram, a receptor activator of nuclear factor kappa-B ligand inhibitor.
Is Q5136 covered by insurance?
Q5136 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for osteoporosis, bone metastases, multiple myeloma, and giant cell tumors of bone.
When is CPT Q5136 used?
Used for osteoporosis, bone metastases, multiple myeloma, and giant cell tumors of bone.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.